Next Article in Journal
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective
Next Article in Special Issue
Chronic Kidney Disease—How Does It Go, and What Can We Do and Expect?
Previous Article in Journal
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
Previous Article in Special Issue
SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
 
 
Review

Article Versions Notes

Biomedicines 2023, 11(2), 470; https://doi.org/10.3390/biomedicines11020470
Action Date Notes Link
article xml file uploaded 6 February 2023 10:40 CET Original file -
article xml uploaded. 6 February 2023 10:40 CET Update -
article pdf uploaded. 6 February 2023 10:40 CET Version of Record -
article html file updated 6 February 2023 10:41 CET Original file -
article xml file uploaded 6 February 2023 10:49 CET Update -
article xml uploaded. 6 February 2023 10:49 CET Update https://www.mdpi.com/2227-9059/11/2/470/xml
article pdf uploaded. 6 February 2023 10:49 CET Updated version of record https://www.mdpi.com/2227-9059/11/2/470/pdf
article html file updated 6 February 2023 10:50 CET Update -
article html file updated 1 March 2023 12:59 CET Update https://www.mdpi.com/2227-9059/11/2/470/html
Back to TopTop